TY - JOUR
T1 - Cationic host defense (antimicrobial) peptides
AU - Brown, Kelly L.
AU - Hancock, Robert E.W.
N1 - Funding Information:
We acknowledge funding from the Canadian Institutes of Health Research and Genome Canada for our own peptide research. KLB is supported by a postdoctoral fellowship from the CIHR-UBC Strategic Training Program for Translational Research in Infectious Diseases (TRID). REWH is the recipient of a Canada Research Chair.
PY - 2006/2
Y1 - 2006/2
N2 - Members of the cationic host defense (antimicrobial) peptide family are widely distributed in nature, existing in organisms from insects to plants to mammals and non-mammalian vertebrates. Although many demonstrate direct antimicrobial activity against bacteria, fungi, eukaryotic parasites and/or viruses, it has been established that cationic peptides have a key modulatory role in the innate immune response. More recent evidence suggests that host defense peptides are effective adjuvants, are synergistic with other immune effectors, polarize the adaptive response, and support wound healing. In addition, the mechanisms of action are being unraveled, which support more effective implementation of derivatives of these endogenous peptides as therapeutic agents.
AB - Members of the cationic host defense (antimicrobial) peptide family are widely distributed in nature, existing in organisms from insects to plants to mammals and non-mammalian vertebrates. Although many demonstrate direct antimicrobial activity against bacteria, fungi, eukaryotic parasites and/or viruses, it has been established that cationic peptides have a key modulatory role in the innate immune response. More recent evidence suggests that host defense peptides are effective adjuvants, are synergistic with other immune effectors, polarize the adaptive response, and support wound healing. In addition, the mechanisms of action are being unraveled, which support more effective implementation of derivatives of these endogenous peptides as therapeutic agents.
UR - https://www.scopus.com/pages/publications/30044452344
U2 - 10.1016/j.coi.2005.11.004
DO - 10.1016/j.coi.2005.11.004
M3 - Review article
C2 - 16337365
AN - SCOPUS:30044452344
SN - 0952-7915
VL - 18
SP - 24
EP - 30
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 1
ER -